SNES icon

SenesTech

5.15 USD
+0.17
3.41%
At close Updated Sep 12, 4:00 PM EDT
1 day
3.41%
5 days
1.18%
1 month
12.2%
3 months
83.93%
6 months
123.91%
Year to date
55.59%
1 year
68.85%
5 years
-99.87%
10 years
-100%
 

About: SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.

Employees: 23

0
Funds holding %
of 7,462 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

3,220% more capital invested

Capital invested by funds: $14.7K [Q1] → $487K (+$472K) [Q2]

167% more funds holding

Funds holding: 3 [Q1] → 8 (+5) [Q2]

4.29% more ownership

Funds ownership: 0.46% [Q1] → 4.75% (+4.29%) [Q2]

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Financial journalist opinion

Based on 3 articles about SNES published over the past 30 days

Neutral
PRNewsWire
4 days ago
SenesTech's Evolve™ Rat Birth Control Now Available Online at HomeDepot.com
Revolutionary, Non-Toxic Solution Expands Consumer Access and Investor Growth Opportunities SURPRISE, Ariz. , Sept. 10, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations, today announced that its groundbreaking Evolve™ Rat Birth Control product is now available to purchase online at HomeDepot.com.
SenesTech's Evolve™ Rat Birth Control Now Available Online at HomeDepot.com
Neutral
PRNewsWire
12 days ago
SenesTech's Evolve™ Deployments Expanded to Additional Chicago Neighborhoods
SURPRISE, Ariz. , Sept. 2, 2025 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES), a pioneer in fertility control solutions for managing rodent populations, today confirmed the latest order for its innovative rodent control solution, Evolve™ Rat Birth Control, to be deployed in Chicago's Old Town Special Service Area #48 (SSA #48).
SenesTech's Evolve™ Deployments Expanded to Additional Chicago Neighborhoods
Neutral
PRNewsWire
26 days ago
SenesTech to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025
SURPRISE, Ariz. , Aug. 18, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control for managing animal pest populations, today announced that it will participate in a webcast presentation at the Lytham Partners 2025 Consumer & Technology Investor Summit, taking place virtually on Tuesday, August 19, 2025.
SenesTech to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025
Neutral
Seeking Alpha
1 month ago
SenesTech, Inc. (SNES) Q2 2025 Earnings Call Transcript
SenesTech, Inc. (NASDAQ:SNES ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Joel L. Fruendt - CEO, President & Director Thomas C.
SenesTech, Inc. (SNES) Q2 2025 Earnings Call Transcript
Neutral
The Motley Fool
1 month ago
SenesTech (SNES) Q2 Sales Jump 36%
SenesTech (SNES) Q2 Sales Jump 36%
SenesTech (SNES) Q2 Sales Jump 36%
Neutral
PRNewsWire
1 month ago
SenesTech Reports Second Quarter 2025 Financial Results with Record Revenue and Record Gross Profit Margins
94% Revenue Growth in Evolve™ Rodent Birth Control Products Strong Cash Balance and Sustained Progress Toward Profitability SURPRISE, Ariz. , Aug. 7, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-registered rodent birth control products today announced its financial results for the second quarter ended June 30, 2025.
SenesTech Reports Second Quarter 2025 Financial Results with Record Revenue and Record Gross Profit Margins
Neutral
PRNewsWire
1 month ago
SenesTech Announces Closing of Warrant Exercise for $6.3 Million in Gross Proceeds
SURPRISE, Ariz. , Aug. 5, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a leader in fertility control for managing animal pest populations, announced today the closing of its previously announced exercise of certain outstanding warrants to purchase an aggregate of 1,458,872 shares of the Company's common stock originally issued by the Company on July 1, 2025, at the existing exercise price of $4.15 per share.
SenesTech Announces Closing of Warrant Exercise for $6.3 Million in Gross Proceeds
Neutral
PRNewsWire
1 month ago
SenesTech Announces Warrant Exercise for $6.3 Million in Gross Proceeds
SURPRISE, Ariz. , Aug. 5, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a leader in fertility control for managing animal pest populations, announced today the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 1,458,872 shares of the Company's common stock originally issued by the Company on July 1, 2025, at the existing exercise price of $4.15 per share.
SenesTech Announces Warrant Exercise for $6.3 Million in Gross Proceeds
Neutral
PRNewsWire
1 month ago
SenesTech to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025
Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time PHOENIX , July 31, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control for managing animal pest populations, will report second quarter 2025 financial results for the period ended June 30, 2025, after the market close on Thursday, August 7, 2025.
SenesTech to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025
Neutral
PRNewsWire
2 months ago
SenesTech Announces Closing of Warrant Exercise for $4.4 Million in Gross Proceeds
SURPRISE, Ariz. , July 1, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a leader in fertility control for managing animal pest populations, announced today the closing of its previously announced exercise of certain outstanding warrants to purchase an aggregate of 1,458,872 shares of the Company's common stock originally issued by the Company on March 11, 2025, at the existing exercise price of $2.90 per share.
SenesTech Announces Closing of Warrant Exercise for $4.4 Million in Gross Proceeds
Charts implemented using Lightweight Charts™